• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

瘤内注射光敏剂联合免疫疗法的光动力疗法为难治性皮肤恶性溃疡患者带来了希望。

Photodynamic therapy with intratumoral injection of photosensitizers combined with immunotherapy brings hope to patients with refractory cutaneous malignant ulcers.

作者信息

Tian Dan, Teng Chong, Lv Yanju, Duan Xiaozhuo, Wang Yi, Song Xiaowei, Jiang Qiuying, Huang Dayong, Xin Tao, Yang Yu, Li Li

机构信息

Department of Oncology, The Second Affiliated Hospital of Harbin Medical University, Harbin, 150081, China.

出版信息

Discov Oncol. 2024 Oct 4;15(1):522. doi: 10.1007/s12672-024-01342-0.

DOI:10.1007/s12672-024-01342-0
PMID:39365490
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11452570/
Abstract

Cutaneous squamous cell carcinoma (CSCC) is common among the elderly, typically treated with surgery. However, for surgery-ineligible patients or those with non-healing wounds progressing to malignant ulcers, non-surgical local treatments are viable. This case details an 80-year-old with recurrent back CSCC and intractable malignant ulcers post-radiotherapy and chemotherapy. Treatment involved Hematoporphyrin Derivative (HpD) Photodynamic Therapy (PDT) with low-dose cindilimab immunotherapy (intravenous and intralesional). Two cycles achieved lesion remission, altering peripheral immune cell counts. HpD-PDT combined with immunotherapy is promising for treating CSCC, particularly with malignant ulcers.

摘要

皮肤鳞状细胞癌(CSCC)在老年人中很常见,通常采用手术治疗。然而,对于不适合手术的患者或伤口不愈合并发展为恶性溃疡的患者,非手术局部治疗是可行的。本病例详细介绍了一名80岁的复发性背部CSCC患者,在放疗和化疗后出现顽固性恶性溃疡。治疗采用血卟啉衍生物(HpD)光动力疗法(PDT)联合低剂量信迪利单抗免疫疗法(静脉注射和瘤内注射)。两个周期后病变缓解,外周免疫细胞计数发生改变。HpD-PDT联合免疫疗法在治疗CSCC方面具有前景,尤其是对于伴有恶性溃疡的患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3a6/11452570/17cc8f44f363/12672_2024_1342_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3a6/11452570/652970a7e104/12672_2024_1342_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3a6/11452570/17cc8f44f363/12672_2024_1342_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3a6/11452570/652970a7e104/12672_2024_1342_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3a6/11452570/17cc8f44f363/12672_2024_1342_Fig2_HTML.jpg

相似文献

1
Photodynamic therapy with intratumoral injection of photosensitizers combined with immunotherapy brings hope to patients with refractory cutaneous malignant ulcers.瘤内注射光敏剂联合免疫疗法的光动力疗法为难治性皮肤恶性溃疡患者带来了希望。
Discov Oncol. 2024 Oct 4;15(1):522. doi: 10.1007/s12672-024-01342-0.
2
Photodynamic therapy with hematoporphyrin derivative for recurrent plantar cutaneous squamous cell carcinoma: A case report.血卟啉衍生物光动力疗法治疗复发性足底皮肤鳞状细胞癌:一例报告
Photodiagnosis Photodyn Ther. 2023 Dec;44:103843. doi: 10.1016/j.pdpdt.2023.103843. Epub 2023 Oct 18.
3
Photodynamic therapy of intravenous injection combined with intratumoral administration of photosensitizer in squamous cell carcinoma.静脉注射光动力疗法联合肿瘤内注射光敏剂治疗鳞状细胞癌。
Photodiagnosis Photodyn Ther. 2022 Jun;38:102857. doi: 10.1016/j.pdpdt.2022.102857. Epub 2022 Apr 8.
4
Case Report: Vaccination by Autologous CD16 Dendritic Cells and Anti-PD-L 1 Antibody Synergized With Radiotherapy To Boost T Cells-Mediated Antitumor Efficacy In A Psoriatic Patient With Cutaneous Squamous Cell Carcinoma.病例报告:自体 CD16 树突状细胞疫苗接种联合抗 PD-L1 抗体与放射治疗协同作用,增强 T 细胞介导的抗肿瘤疗效,用于治疗患有皮肤鳞状细胞癌的银屑病患者。
Front Immunol. 2021 Dec 23;12:752563. doi: 10.3389/fimmu.2021.752563. eCollection 2021.
5
Increased CD56 expression after photodynamic therapy indicates an increased natural killer cell count following early photodynamic therapy for cutaneous squamous cell carcinoma.光动力治疗后CD56表达增加表明皮肤鳞状细胞癌早期光动力治疗后自然杀伤细胞计数增加。
Oncol Lett. 2024 Jun 13;28(2):372. doi: 10.3892/ol.2024.14505. eCollection 2024 Aug.
6
A photodynamic therapy combined with topical 5-aminolevulinic acid and systemic hematoporphyrin derivative is more efficient but less phototoxic for cancer.一种将局部应用5-氨基酮戊酸与全身应用血卟啉衍生物相结合的光动力疗法对癌症更有效,但光毒性更小。
J Cancer Res Clin Oncol. 2016 Apr;142(4):813-21. doi: 10.1007/s00432-015-2066-3. Epub 2015 Nov 18.
7
Photofrin-mediated photodynamic therapy for treatment of aggressive head and neck nonmelanomatous skin tumors in elderly patients.光动力疗法治疗老年侵袭性头颈部非黑素瘤性皮肤肿瘤。
Laryngoscope. 2001 Jun;111(6):1091-8. doi: 10.1097/00005537-200106000-00030.
8
Response of advanced cutaneous squamous cell carcinoma to immunotherapy: case report.晚期皮肤鳞状细胞癌对免疫疗法的反应:病例报告
Stem Cell Investig. 2021 Sep 6;8:19. doi: 10.21037/sci-2020-071. eCollection 2021.
9
Treatment of nasal squamous cell carcinoma with combination of surgery and photodynamic therapy.手术联合光动力疗法治疗鼻腔鳞状细胞癌。
Photodiagnosis Photodyn Ther. 2023 Dec;44:103844. doi: 10.1016/j.pdpdt.2023.103844. Epub 2023 Oct 12.
10
Efficacy of hematoporphyrin injection (HpD) photodynamic therapy in the treatment of widespread extramammary Paget's disease.血卟啉注射液(HpD)光动力疗法治疗广泛的乳腺外派杰氏病的疗效。
Photodiagnosis Photodyn Ther. 2023 Jun;42:103649. doi: 10.1016/j.pdpdt.2023.103649. Epub 2023 Jun 9.

引用本文的文献

1
Trends and emerging frontiers of photodynamic therapy for non-melanoma skin cancer (1979-October 2024): a bibliometric analysis.非黑色素瘤皮肤癌光动力疗法的趋势与新兴前沿(1979年 - 2024年10月):一项文献计量分析
Front Oncol. 2025 Jul 7;15:1580453. doi: 10.3389/fonc.2025.1580453. eCollection 2025.
2
The Role of Nitric Oxide in Cancer Treatment: Ally or Foe?一氧化氮在癌症治疗中的作用:盟友还是敌人?
Molecules. 2025 Jun 29;30(13):2802. doi: 10.3390/molecules30132802.

本文引用的文献

1
Association of Immune-Related Adverse Events, Hospitalization, and Therapy Resumption With Survival Among Patients With Metastatic Melanoma Receiving Single-Agent or Combination Immunotherapy.免疫相关不良事件、住院和治疗恢复与接受单药或联合免疫治疗的转移性黑色素瘤患者生存的关系。
JAMA Netw Open. 2022 Dec 1;5(12):e2245596. doi: 10.1001/jamanetworkopen.2022.45596.
2
Immunogenic Cell Death Activates the Tumor Immune Microenvironment to Boost the Immunotherapy Efficiency.免疫原性细胞死亡激活肿瘤免疫微环境以提高免疫治疗效率。
Adv Sci (Weinh). 2022 Aug;9(22):e2201734. doi: 10.1002/advs.202201734. Epub 2022 Jun 2.
3
Photodynamic therapy of intravenous injection combined with intratumoral administration of photosensitizer in squamous cell carcinoma.
静脉注射光动力疗法联合肿瘤内注射光敏剂治疗鳞状细胞癌。
Photodiagnosis Photodyn Ther. 2022 Jun;38:102857. doi: 10.1016/j.pdpdt.2022.102857. Epub 2022 Apr 8.
4
PD-L1 blockade potentiates the antitumor effects of ALA-PDT and optimizes the tumor microenvironment in cutaneous squamous cell carcinoma.PD-L1 阻断增强了 ALA-PDT 对皮肤鳞状细胞癌的抗肿瘤作用,并优化了肿瘤微环境。
Oncoimmunology. 2022 Apr 3;11(1):2061396. doi: 10.1080/2162402X.2022.2061396. eCollection 2022.
5
Photodynamic therapy synergizes with PD-L1 checkpoint blockade for immunotherapy of CRC by multifunctional nanoparticles.多功能纳米颗粒的光动力疗法与 PD-L1 检查点阻断协同作用,用于 CRC 的免疫治疗。
Mol Ther. 2021 Oct 6;29(10):2931-2948. doi: 10.1016/j.ymthe.2021.05.017. Epub 2021 May 21.
6
Targeting immunogenic cancer cell death by photodynamic therapy: past, present and future.通过光动力疗法靶向免疫原性癌细胞死亡:过去、现在和未来。
J Immunother Cancer. 2021 Jan;9(1). doi: 10.1136/jitc-2020-001926.
7
Basal Cell and Cutaneous Squamous Cell Carcinomas: Diagnosis and Treatment.基底细胞和皮肤鳞状细胞癌:诊断与治疗。
Am Fam Physician. 2020 Sep 15;102(6):339-346.
8
Association of Disease Recurrence With Survival Outcomes in Patients With Cutaneous Squamous Cell Carcinoma of the Head and Neck Treated With Multimodality Therapy.多模态治疗对头颈部皮肤鳞状细胞癌患者的疾病复发与生存结局的相关性。
JAMA Dermatol. 2019 Apr 1;155(4):442-447. doi: 10.1001/jamadermatol.2018.5453.
9
Cutaneous Squamous Cell Carcinoma.皮肤鳞状细胞癌。
Hematol Oncol Clin North Am. 2019 Feb;33(1):1-12. doi: 10.1016/j.hoc.2018.08.001.
10
Influence of photodynamic therapy on peripheral immune cell populations and cytokine concentrations in head and neck cancer.光动力疗法对头颈部癌外周免疫细胞群和细胞因子浓度的影响。
Photodiagnosis Photodyn Ther. 2017 Sep;19:194-201. doi: 10.1016/j.pdpdt.2017.05.015. Epub 2017 May 31.